StonvexLoading…
StonvexStonvexStonvexCore line items from IRMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $83.81M | $73.24M | $65.56M | $53.30M |
Operating Income | $26.15M | $21.96M | $20.04M | $15.63M |
Net Income | $22.48M | $19.23M | $17.19M | $12.83M |
EPS (Diluted) | $1.75 | $1.50 | $1.35 | $1.02 |
Total Assets | $108.78M | $98.33M | $92.16M | $85.51M |
Total Liabilities | $14.16M | $11.51M | $20.74M | $11.84M |
Cash & Equivalents | $51.16M | $52.23M | $49.76M | $57.96M |
Free Cash Flow OCF − CapEx | $17.18M | $17.62M | $6.02M | $9.22M |
Shares Outstanding | 12.78M | 12.71M | 12.66M | 12.59M |